c-Met ectodomain shedding rate correlates with malignant potential

被引:74
作者
Athauda, Gagani
Giubellino, Alessio
Coleman, Jonathan A.
Horak, Christine
Steeg, Patricia S.
Lee, Ming-Jung
Trepel, Jane
Wimberly, Jennifer
Sun, Jan
Coxon, Angela
Burgess, Teresa L.
Bottaro, Donald P.
机构
[1] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA
[3] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA
[4] Georgetown Univ, Sch Med, Dept Urol, Washington, DC USA
[5] Amgen Inc, Dept Canc Biol, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1158/1078-0432.CCR-06-0250
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Many proteins are proteolytically released from the cell surface by a process known as ectodomain shedding. Shedding occurs under normal physiologic conditions and can be increased in certain pathologies. Among the many receptors for which ectodomain shedding has been shown is c-Met, the hepatocyte growth factor (HGF) receptor tyrosine kinase. HGF stimulates mitogenesis, motogenesis, and morphogenesis in a variety of cellular targets during development, homeostasis, and tissue regeneration. Inappropriate HGF signaling resulting in unregulated cell proliferation, motility, and invasion occurs in several human malignancies. This can occur through paracrine signaling, autocrine loop formation, receptor mutation, gene amplification, or gene rearrangement, accompanied frequently with overexpression of ligand and/or receptor proteins. We hypothesized that c-Met overexpression in cancer might result in increased ectodomain shedding, and that its measure could be a useful biomarker of tumor progression. Experimental Design: We developed a sensitive electrochemiluminescent immunoassay to quantitate c-Met protein in cell lysates, culture supernatants, and biological samples. Results: A survey of cultured cell models of oncogenic transformation revealed significant direct correlations (P < 0.001, t test or ANOVA) between malignant potential and the rate of c-Met ectodomain shedding that was independent of steady-state receptor expression level, Moreover, weekly plasma and urine samples from mice harboring s.c. human tumor xenografts (n = 4 per group) displayed soluble human c-Met levels that were measurable before tumors became palpable and that correlated directly with tumor volume (R-2 > 0.92, linear regression). Conclusions: For a variety of human cancers, c-Met ectodomain shedding may provide a reliable and practical indicator of malignant potential and overall tumor burden.
引用
收藏
页码:4154 / 4162
页数:9
相关论文
共 39 条
[1]   CDNA STRUCTURES AND REGULATION OF 2 INTERFERON-INDUCED HUMAN MX PROTEINS [J].
AEBI, M ;
FAH, J ;
HURT, N ;
SAMUEL, CE ;
THOMIS, D ;
BAZZIGHER, L ;
PAVLOVIC, J ;
HALLER, O ;
STAEHELI, P .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (11) :5062-5072
[2]   Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase [J].
Birchmeier, C ;
Gherardi, E .
TRENDS IN CELL BIOLOGY, 1998, 8 (10) :404-410
[3]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[4]  
Birchmeier W, 1997, CIBA F SYMP, V212, P230
[5]   Adams: Key components in EGFR signalling and development [J].
Blobel, CP .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (01) :32-43
[6]   Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors [J].
Burgess, T ;
Coxon, A ;
Meyer, S ;
Sun, J ;
Rex, K ;
Tsuruda, T ;
Chen, Q ;
Ho, SY ;
Li, L ;
Kaufman, S ;
McDorman, K ;
Cattley, RC ;
Sun, JL ;
Elliott, G ;
Zhang, K ;
Feng, X ;
Jia, XC ;
Green, L ;
Radinsky, R ;
Kendall, R .
CANCER RESEARCH, 2006, 66 (03) :1721-1729
[7]   Induction of tissue inhibitor of metalloproteinases-3 is a delayed early cellular response to hepatocyte growth factor [J].
Castagnino, P ;
Soriano, JV ;
Montesano, R ;
Bottaro, DP .
ONCOGENE, 1998, 17 (04) :481-492
[8]   Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder:: A comparison with p53 nuclear accumulation [J].
Cheng, HL ;
Trink, B ;
Tzai, TS ;
Liu, HS ;
Chan, SH ;
Ho, CL ;
Sidransky, D ;
Chow, NH .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1544-1550
[9]   Genetic abnormalities specifically associated with varying metastatic potential of prostate cancer cell lines as detected by comparative genomic hybridization [J].
Chu, LW ;
Pettaway, CA ;
Liang, JC .
CANCER GENETICS AND CYTOGENETICS, 2001, 127 (02) :161-167
[10]   Scatter factors and invasive growth [J].
Comoglio, PM ;
Boccaccio, C .
SEMINARS IN CANCER BIOLOGY, 2001, 11 (02) :153-165